Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
2.440
+0.370 (17.87%)
At close: Mar 23, 2026, 4:00 PM EDT
2.450
+0.010 (0.41%)
Pre-market: Mar 24, 2026, 8:45 AM EDT
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $594.82 million as of March 24, 2026. Its market cap has increased by 30.13% in one year.
Market Cap
594.82M
Enterprise Value
427.86M
1-Year Change
30.13%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $594.82M, a decrease of -79.35%. That is a compound annual growth rate of -19.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 593.60M | 92.80% |
| Dec 31, 2025 | 307.88M | -31.06% |
| Dec 31, 2024 | 446.60M | -17.32% |
| Dec 29, 2023 | 540.17M | -40.45% |
| Dec 30, 2022 | 907.08M | -57.34% |
| Dec 31, 2021 | 2.13B | -39.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alpha Tau Medical | 633.67M |
| Eikon Therapeutics | 632.16M |
| MiMedx Group | 629.92M |
| Design Therapeutics | 627.21M |
| MeiraGTx Holdings | 615.76M |
| Relmada Therapeutics | 614.66M |
| LB Pharmaceuticals | 598.83M |
| AgomAb Therapeutics NV | 597.03M |